Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX vaccine in advanced-stage non-small-cell lung cancer. [electronic resource]
Producer: 20060925Description: 555-62 p. digitalISSN:- 0929-1903
- Adult
- Aged
- Cancer Vaccines -- adverse effects
- Carcinoma, Non-Small-Cell Lung -- immunology
- Female
- Granulocyte-Macrophage Colony-Stimulating Factor -- adverse effects
- Humans
- K562 Cells
- Lung Neoplasms -- immunology
- Male
- Middle Aged
- Neoplasm Staging
- Patient Selection
- Transplantation, Homologous
- Treatment Outcome
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.